LOS ANGELES, Oct. 27, 2017 /PRNewswire/ -- CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced the results of the Special Meeting of Stockholders which took place earlier today at 10100 Santa Monica Blvd., Los Angeles, CA 90067. At the meeting, the proposed 1-for-6 reverse stock split resolution was approved by CytRx stockholders with more than twice as many shares voting FOR than AGAINST.
...
http://www.ariva.de/news/...s-results-from-special-meeting-of-6568191
...
http://www.ariva.de/news/...s-results-from-special-meeting-of-6568191